A detailed history of Group One Trading, L.P. transactions in Veru Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 71,213 shares of VERU stock, worth $52,697. This represents 0.0% of its overall portfolio holdings.

Number of Shares
71,213
Previous 22,932 210.54%
Holding current value
$52,697
Previous $16,000 268.75%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.76 - $1.79 $36,693 - $86,422
48,281 Added 210.54%
71,213 $59,000
Q1 2024

May 10, 2024

SELL
$0.37 - $0.72 $9,195 - $17,893
-24,852 Reduced 52.01%
22,932 $16,000
Q4 2023

Feb 14, 2024

BUY
$0.67 - $1.17 $21,096 - $36,840
31,488 Added 193.23%
47,784 $34,000
Q3 2023

Nov 09, 2023

BUY
$0.72 - $1.33 $11,733 - $21,673
16,296 New
16,296 $11,000
Q3 2022

Nov 09, 2022

BUY
$10.22 - $23.7 $198,870 - $461,178
19,459 New
19,459 $224,000
Q2 2022

Aug 11, 2022

SELL
$4.35 - $15.85 $409,130 - $1.49 Million
-94,053 Closed
0 $0
Q1 2022

May 12, 2022

SELL
$4.55 - $6.41 $185,330 - $261,092
-40,732 Reduced 30.22%
94,053 $454,000
Q4 2021

Feb 11, 2022

BUY
$5.89 - $9.73 $366,864 - $606,042
62,286 Added 85.91%
134,785 $794,000
Q3 2021

Nov 12, 2021

BUY
$6.78 - $9.89 $491,543 - $717,015
72,499 New
72,499 $618,000
Q1 2021

May 12, 2021

SELL
$8.05 - $20.78 $382,994 - $988,650
-47,577 Closed
0 $0
Q4 2020

Feb 10, 2021

BUY
$2.36 - $9.99 $78,394 - $331,847
33,218 Added 231.34%
47,577 $412,000
Q3 2020

Nov 12, 2020

BUY
$2.58 - $3.36 $37,046 - $48,246
14,359 New
14,359 $38,000
Q4 2018

Feb 06, 2019

SELL
$1.21 - $1.54 $76,445 - $97,294
-63,178 Closed
0 $0
Q3 2018

Nov 08, 2018

BUY
$1.38 - $2.27 $23,597 - $38,817
17,100 Added 37.11%
63,178 $90,000
Q2 2018

Aug 14, 2018

BUY
$1.64 - $2.29 $75,567 - $105,518
46,078 New
46,078 $93,000

Others Institutions Holding VERU

About VERU INC.


  • Ticker VERU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,146,704
  • Market Cap $59.3M
  • Description
  • Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....
More about VERU
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.